Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
75.56
-0.22 (-0.29%)
At close: May 22, 2026, 4:00 PM EDT
76.06
+0.50 (0.66%)
After-hours: May 22, 2026, 5:31 PM EDT

Ionis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,48712,9195,5207,3025,3664,297
Market Cap Growth
146.26%134.02%-24.40%36.09%24.87%-45.86%
Enterprise Value
13,12011,8514,6306,3714,7403,430
Last Close Price
75.5679.1134.9650.5937.7730.43
PS Ratio
11.8013.697.839.279.135.30
PB Ratio
25.5126.419.3818.899.375.57
P/TBV Ratio
25.7225.888.8818.749.355.56
P/FCF Ratio
-----228.03
P/OCF Ratio
-----139.52
EV/Sales Ratio
12.4012.566.578.098.074.23
EV/FCF Ratio
-----182.00
Debt / Equity Ratio
3.273.292.393.622.381.62
Debt / FCF Ratio
-----66.20
Net Debt / Equity Ratio
0.25-1.30-1.51-2.29-1.09-1.12
Net Debt / EBITDA Ratio
-0.371.771.972.681.6181.64
Net Debt / FCF Ratio
-0.121.991.632.682.15-46.03
Asset Turnover
0.300.290.240.290.230.32
Inventory Turnover
2.231.411.120.620.600.46
Quick Ratio
2.783.517.735.426.469.05
Current Ratio
4.103.838.475.907.079.75
Return on Equity (ROE)
-66.70%-70.80%-93.10%-76.34%-40.12%-3.78%
Return on Assets (ROA)
-10.16%-11.75%-15.64%-14.05%-16.67%-1.18%
Return on Invested Capital (ROIC)
-36.56%-70.95%-103.90%-102.50%-123.01%-8.69%
Return on Capital Employed (ROCE)
-12.87%-14.04%-18.15%-14.85%-17.86%-1.45%
FCF Yield
-----0.44%
Buyback Yield / Dilution
-5.71%-7.02%-4.42%-0.95%-0.59%-1.01%
Total Shareholder Return
-5.71%-7.02%-4.42%-0.95%-0.59%-1.01%
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q